Skip to main content

Advertisement

SpringerLink
Log in

The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma

  • Gynecologic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Objectives

This study was designed to evaluate the detection rate (DR) and sensitivity of sentinel lymph node (SLN) mapping in patients with endometrial cancer using TC99m colloid and blue dye and to evaluate the contribution of preoperative planar lymphoscintigraphy (PLSG) and SPECT/CT.

Methods

A retrospective analysis of patients who underwent SLN mapping as part of their primary surgery for endometrial cancer. Patients underwent preoperative PLSG and later with additional SPECT/CT. Intraoperative detection was performed using TC99m colloid and blue dye by cervical injections. SLNs were sent separately for pathologic evaluation with ultrastaging.

Results

Fifty-three patients were included in this study. Successful preoperative mapping was achieved in 31 of 37 patients (84 %) who underwent SPECT/CT compared with only 30 of 45 patients (67 %) who underwent PLSG. SPECT/CT localizations of SLNs were anatomically accurate in 91 % of cases. Intraoperative DR of at least one SLN was 77 %, whilst the bilateral DR was 49 %. DR was significantly better using combined blue dye and TC99m colloid injections compared with blue dye alone: 81 versus 57 % for unilateral and 54 versus 28 % for bilateral mapping (P = 0.01, 0.009, respectively). Six cases of nodal metastasis were diagnosed: four by positive SLNs, and two cases were diagnosed using side-specific full dissection according to the SLN algorithm when SLN detection failed. There were no cases of false-negative results.

Conclusions

SLN detection using cervical injections of TC99m colloid and blue dye is feasible and sensitive for patients with endometrial cancer. SPECT/CT aids to accurate locating of the SLN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106(2):413–25.

  2. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.

    Article  PubMed  CAS  Google Scholar 

  3. Panici BP, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.

    Article  Google Scholar 

  4. Yost KJ, Cheville AL, Al-Hilli MM, et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol. 2014;124:307–15.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kim CH, Soslow RA, Park KJ, et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer. 2013;23:964–70.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Raimond E, Ballester M, Hudry D, et al. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol. 2014;133(3):506–11.

    Article  PubMed  Google Scholar 

  7. How J, Lau S, Press J, et al. Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol. 2012;127:332–7.

    Article  PubMed  Google Scholar 

  8. Khoury-Collado F, Glaser GE, Zivanovic OA, et al. Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed? Gynecol Oncol. 2009;115:453–5.

    Article  PubMed  Google Scholar 

  9. Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol. 2010;117:59–64.

    Article  PubMed  Google Scholar 

  10. Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125(3):531–5.

    Article  PubMed  Google Scholar 

  11. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.

    Article  PubMed  Google Scholar 

  12. Phan GQ, Messina JL, Sondak VK, Zager JS. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control. 2009;16(3):234–9.

    PubMed  Google Scholar 

  13. Thompson CF, St John MA, Lawson G, Grogan T, Elashoff D, Mendelsohn AH. Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol. 2013;270(7):2115–22.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.

    Article  PubMed  Google Scholar 

  15. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30(31):3786-91.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Robison K, Roque D, McCourt C, et al. Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecol Oncol. 2014;133(3):416–20.

    Article  PubMed  Google Scholar 

  17. Cibula D, Abu-Rustum NR, Ladislav Dusek, et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol. 2012;127:462–6.

    Article  PubMed  Google Scholar 

  18. Altgassen C, Hertel H, Brandstadt A, et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. JCO 2008;26(18):2943–51.

    Article  Google Scholar 

  19. Van de Lande J, Torrenga B, Raijmakers P, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol. 2007;106:604–13.

    Article  PubMed  Google Scholar 

  20. Martínez A, Mery E, Filleron T, Boileau L, Ferron G, Querleu D. Accuracy of intraoperative pathological examination of SLN in cervical cancer. Gynecol Oncol. 2013;130:525–9.

    Article  PubMed  Google Scholar 

  21. Zaal A, Zweemer RP, Zikán M, et al. Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study. Int J Gynecol Cancer. 2014;24(2):303–11.

    Article  PubMed  Google Scholar 

  22. Kraft O, Havel M. Sentinel lymph nodes and planar scintigraphy and SPECT/CT in various types of tumours. Estimation of some factors influencing detection success. Nucl Med Rev. 2013;1:17–25.

    Google Scholar 

  23. Hoogendam JP, Hobbelink MGG, Veldhuis WB, Verheijen RHM, Van Diest PJ, Zweemer RP. Preoperative sentinel node mapping with 99 mTc-nanocolloid SPECT–CT significantly reduces the intraoperative sentinel node retrieval time in robot assisted laparoscopic cervical cancer surgery. Gynecol Oncol. 2013;129:389–94.

    Article  PubMed  Google Scholar 

  24. Leppänen E, Leidenius M, Krogerus L, von Smitten K. The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol. 2002;28(8):821–6.

    Article  PubMed  Google Scholar 

  25. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Solima E, Martinelli F, Ditto A, et al. Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer. Gynecol Oncol. 2012;126:419–23.

    Article  PubMed  Google Scholar 

  27. Kim CH, Khoury-Collado F, Barber EL, et al. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. Gynecol Oncol. 2013;131(3):714–9.

    Article  PubMed  Google Scholar 

  28. Orr JW, Holloway RW, Orr PF, Holimon JL. Surgical staging of uterine cancer: an analysis of perioperative morbidity. Gynecol Oncol. 1991;42:209–16.

    Article  PubMed  Google Scholar 

  29. Abu-Rustum NR. Update on sentinel node mapping in uterine cancer: 10 year experience at Memorial Sloan–Kettering Cancer Center. J Obstet Gynaecol Res. 2014;40:327–34.

    Article  PubMed  Google Scholar 

Download references

Disclosure

The authors declare that there is no financial interest or any other potential conflict of interest.

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, Kaplan Medical Center, Rehovot, Israel

    Y. Naaman MD, N. Oustinov MD, E. Vaisbuch MD & A. Ben-Arie MD

  2. Department of Nuclear Medicine, Kaplan Medical Center, Rehovot, Israel

    L. Pinkas MD & S. Roitman BA

  3. Department of Pathology, Kaplan Medical Center, Rehovot, Israel

    S. Ikher MD

  4. Department of Oncology, Kaplan Medical Center, Rehovot, Israel

    A. Yachnin MD

  5. Faculty of Medicine, The Hebrew University, Jerusalem, Israel

    Y. Naaman MD, L. Pinkas MD, S. Roitman BA, S. Ikher MD, N. Oustinov MD, E. Vaisbuch MD, A. Yachnin MD & A. Ben-Arie MD

Authors
  1. Y. Naaman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Pinkas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Roitman BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Ikher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Oustinov MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Vaisbuch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Yachnin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Ben-Arie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Naaman MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naaman, Y., Pinkas, L., Roitman, S. et al. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma. Ann Surg Oncol 23, 450–455 (2016). https://doi.org/10.1245/s10434-015-4877-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4877-5

Keywords

Search

Navigation